Dovalue SpA
LSE:0RTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dovalue SpA
LSE:0RTI
|
IT |
|
Olectra Greentech Ltd
BSE:532439
|
IN |
|
A
|
Apollo Medical Holdings Inc
F:3AM
|
US |
|
C
|
China Reinsurance Group Corp
F:C53
|
CN |
|
B
|
Babcock International Group PLC
DUS:BW3
|
UK |
|
S
|
Starwood Property Trust Inc
XBER:VSP
|
US |
|
ZTO Express (Cayman) Inc
LSE:0A33
|
CN |
|
C
|
Critical Elements Lithium Corp
SWB:F12
|
CA |
|
Syntara Ltd
F:UUDA
|
AU |
Wall St Price Targets
0RTI Price Targets Summary
Dovalue SpA
According to Wall Street analysts, the average 1-year price target for 0RTI is 3.441 EUR with a low forecast of 2.621 EUR and a high forecast of 4.087 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RTI's stock price target?
Price Target
3.441
EUR
According to Wall Street analysts, the average 1-year price target for 0RTI is 3.441 EUR with a low forecast of 2.621 EUR and a high forecast of 4.087 EUR.
What is the Revenue forecast for Dovalue SpA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Dovalue SpA?
Projected CAGR
25%
The compound annual growth rate for Operating Income over the next 3 years is 25%.
